Skip to content
Independent analysis of NHS open data
PharmaInsight

Elvitegravir/Cobicistat/Emtricitabine/Tenofovir alafenamide vs Entecavir

National NHS prescribing compared (Prescription Cost Analysis)
Data updated January 2026

Entecavir was dispensed 93.0× as often as Elvitegravir/Cobicistat/Emtricitabine/Tenofovir alafenamide in January 2026 — 279 items versus 3 in England.

3items

Elvitegravir/Cobicistat/Emtricitabine/Tenofovir alafenamide · January 2026

NHSBSA Prescription Cost Analysis

279items

Entecavir · January 2026

NHSBSA Prescription Cost Analysis

Figure 1. Elvitegravir/Cobicistat/Emtricitabine/Tenofovir alafenamide versus Entecavir: national items dispensed by month

▬ Elvitegravir/Cobicistat/Emtricitabine/Tenofovir alafenamide   ·   ╌ Entecavir

0 150 300 Jan 2026 Entecavir 3 Jan 2026: 3

Source: NHSBSA Prescription Cost Analysis, to January 2026

Elvitegravir/Cobicistat/Emtricitabine/Tenofovir alafenamide versus Entecavir, January 2026
Measure Elvitegravir/Cobicistat/Emtricitabine/Tenofovir alafenamide Entecavir
Items, January 2026 3 279
Items, last 12 months 3 3,325
Net ingredient cost, January 2026 £88 £138,668

See the full profile for Elvitegravir/Cobicistat/Emtricitabine/Tenofovir alafenamide or Entecavir.